Evidence map›Paper›PMID 39714835›Full record

ArticleJAMA dermatology2025

Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age.

Lauren A V Orenstein, John S Barbieri, Meron Siira, Ethan Borre, Krittin J Supapannachart, Eric Viera, Courtney Ann Prestwood, Robert Swerlick, Rachel E Patzer, Suephy C Chen

Abstract readMulticenter Study
In one paragraph

Article in JAMA dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lauren A V OrensteinDepartment of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
John S BarbieriDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Meron SiiraDepartment of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
Ethan BorreDepartment of Dermatology, Duke University, Durham, North Carolina.
Krittin J SupapannachartDepartment of Dermatology, University of San Francisco, San Francisco, California.
Eric VieraDepartment of Biostatistics, Emory University Rollins School of Public Health, Atlanta, Georgia.
Courtney Ann PrestwoodDepartment of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
Robert SwerlickDepartment of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
Rachel E PatzerDepartment of Surgery, Indiana University School of Medicine, Indianapolis.
Suephy C ChenDepartment of Dermatology, Duke University, Durham, North Carolina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Clinical productivity measures may incentivize clinical care to specific patient populations and thus perpetuate inequitable care. Before the 2021 Medicare physician fee schedule changes, outpatient dermatology encounters for patients who were younger, female, and races other than White systematically generated fewer work relative value units (wRVUs). Objective: To examine the association of patient race, age, and sex with wRVUs generated by outpatient dermatology encounters after 2021. Design, Setting, and Participants: This multi-institutional cross-sectional study evaluated demographic and billing data for outpatient dermatology encounters across 3 academic dermatology practices. The study compared wRVUs generated by outpatient general dermatology encounters in 6-month periods before and after the 2021 fee schedule updates (March 1 to August 31, 2019, and March 1 to August 31, 2021). Eligibility required an age of 18 years or older and available age, race, and sex data. Data analysis was performed from September 2022 to March 2024. Main Outcomes and Measures: The primary outcome was wRVUs generated per encounter. Results: This study included 89 656 encounters (47 607 before the 2021 Medicare physician fee schedule update and 42 049 after the update). Across all encounters, the mean (SD) patient age was 56.3 (17.8) years; 55 460 encounters (61.9%) were with female patients and 34 196 (38.1%) were with male patients; and 3457 encounters (3.9%) were with Asian patients, 10 478 (11.7%) with Black patients, 72 894 (81.3%) with White patients, and 2287 (3.2%) with patients of other race or ethnicity (Latino and multiracial). The mean (SD) wRVUs per outpatient dermatology encounter was 1.44 (0.88) before the update and 1.80 (0.99) after (P < .001). After 2021, adjusted analyses demonstrated significantly fewer wRVUs per encounter for female (β, -0.11; 95% CI, -0.13 to -0.10) compared with male patients, and for younger (β, 0.04 [95% CI, 0.04 to 0.05] per 10-year increase in age) compared with older patients. After the update, compared with White patients, visits with Asian patients generated fewer wRVUs (β, -0.12; 95% CI, -0.17 to -0.08) as did visits with Black patients (β, -0.14; 95% CI, -0.17 to -0.11), both statistically significant reductions compared with prior comparisons (P < .001 for both). After 2021, mediation analysis identified that premalignant destructions and biopsies mediated many of the remaining differences in wRVU generation by patient age, race, and sex. Conclusions and Relevance: This study found that after the 2021 Medicare fee schedule updates, there was a persistent, albeit reduced, gap between wRVU productivity in outpatient dermatology visits for Asian and Black compared with White patients. These persisting differences were attributable to skin biopsies and cryotherapy of premalignant lesions.

Indexed as

Ambulatory CareDermatologyEfficiencyRacial GroupsAdultAgedAged, 80 and overAge FactorsCross-Sectional StudiesFemaleHumansMaleMedicareMiddle AgedOutpatientsRelative Value Scales

Identifiers

PMID39714835
PMCPMC11923712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.